Beranda › Kanker Paru › Ohio › Youngstown
Uji klinis Kanker Paru di Youngstown, OH
4 studi untuk Kanker Paru mencari peserta di lokasi sekitar Youngstown (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- UPMC Cancer Center at UPMC Horizon, Farrell · 11 mi jauhnya
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Saint Elizabeth Youngstown Hospital, Youngstown
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- UPMC Cancer Center at UPMC Horizon, Farrell · 11 mi jauhnya
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- UPMC Cancer Center at UPMC Horizon, Farrell · 11 mi jauhnya
Uji klinis Kanker Paru di kota lain
- Houston, TX78 studi
- Boston, MA62 studi
- New York City, NY60 studi
- Los Angeles, CA45 studi
- Washington, DC41 studi
- Arlington, VA41 studi
- Chicago, IL41 studi
- Nashville, TN40 studi
- Baltimore, MD40 studi
- St. Louis, MO39 studi
- Columbus, OH37 studi
- Philadelphia, PA36 studi
Studi lain di Youngstown
- Kanker Paru Non-Sel Kecil5 studi
- Karsinoma Sel Skuamosa Kepala dan Leher5 studi
- Kanker Kolorektal5 studi
- Kanker Mulut4 studi
- Kanker Payudara4 studi
- Kanker Prostat4 studi
- Kanker Laring3 studi
- Melanoma3 studi
- Kanker Ginjal (Karsinoma Sel Renal)3 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.